Two POLE Leu424Val heterozygotes developed glioblastomas at age 47 and age 61 respectively, one Leu424Val heterozygote developed an astrocytoma at age 15 and one Leu424Val heterozygote developed an oligodendroglioma aged 30. The gene discussed is POLE; the disease is glioblastoma.